Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Biotinylated Mouse PD-L1 / B7-H1, Fc Tag, Avi Tag (Avitag™), 25µg  

Recombinant Biotinylated Mouse PD-L1 / B7-H1, Fc Tag, Avi Tag (Avitag™), 25µg

Recombinant Biotinylated Mouse PD-L1 / B7-H1 Protein, AA Phe 19 - Thr 238, expressed from human HEK293 cells, Fc,Avitag™

Synonym
recombinant, PD-L1, CD274, B7-H1, PDCD1L1, PDCD1LG1

More details

PD1-M82F5-25

Availability: within 7 days

455,00 €

Background
Programmed cell death 1 ligand 1 (PDL1) is also known as B7-H, B7H1, MGC142294, MGC142296, PD-L1, PDCD1L1 and PDCD1LG1,which is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses.PDL1 is a cell surface immunoglobulin superfamily with two Ig-like domains within the extracellular region and a short cytoplasmic domain. This protein is broadly expressed in the majority of peripheral tissues as well as hematopoietic cells. Interaction between PDL1 and its receptors belonging to the CD28 family of molecules provide both stimulatory and inhibitory signals in regulating T cell activation and tolerance. PDL1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression.

Source
Recombinant MABSol® Biotinylated Mouse PD-L1, Fc,Avitag (PD1-M82F5) is expressed from human HEK293 cells. It contains AA Phe 19 - Thr 238 (Accession # NP_068693).
Predicted N-terminus: Phe 19

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag (Avitag™).
The protein has a calculated MW of 53.2 kDa. The protein migrates as 65-85 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Biotinylation
Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

Biotin:Protein Ratio

Passed as determined by the HABA assay / binding ELISA.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1) "Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)"
Day, Sridharan, Lynam et al
BMC Cancer (2022) 22 (1), 1324
(2) "Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients"
Tong, Huang, Ren et al
Eur J Med Res (2022) 27 (1), 293
(3) "Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer"
Bell, Huber, Singhal et al
Cell Metab (2022)
Showing 1-3 of 23082 papers.